Skip to main content

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings

Shares (Q2 2026)
38,158
Value
$706.9K
% of portfolio
<0.1%
Quarters held
3
Since Q3 2025
Holdings of AVTX by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202638,158$706.9K<0.1%−2,663−6.5%ReducedHolders
Q1 202640,821$607.3K<0.1%+40,821NewHolders
Q4 20250$00.0%−11,215−100.0%Sold outHolders
Q3 202511,215$143.2K<0.1%+11,215NewHolders